Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Estradiol Replacement Therapy in Premature Ovarian Failure
NCT00370019Phase 2Withdrawn
- Sponsor
- Eunice Kennedy Shriver National Institute of Child Health and Human Development
- Start
- Aug 2006
- Primary completion
- Dec 2011
- Modality
- Hormone, Biologic
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in primary ovarian insufficiency (POI) comparing Estradiol + Progestin with Placebo (2 arms). Primary endpoint: Serum progesterone in the ovulatory range. Planned start Aug 2006; status: withdrawn.
02
Drugs
estradiol
03
Conditions
primary ovarian insufficiency (POI)
Beyond the preview
Go deeper on NCT00370019.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00370019.